Not exact matches
Several analysts highlighted
continued uncertainty at Deutsche Bank following its management change, despite shares of the German lender
seeing an initial jump Monday morning.
These risks and
uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or
continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs);
continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not
see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
«We were particularly encouraged to
see fiscal discipline in light of the
continued economic
uncertainty seen elsewhere in Canada and the world, the establishment of a commission on tax competitiveness to evaluate current taxation instruments like the provincial sales tax, and proposed changes to the property transfer tax to start addressing housing affordability by increasing the exemption threshold and introducing a third tax rate on higher - valued properties.»
We may
see some more
uncertainty ahead of earnings releases and investors will
continue to react to bonds yield changes.
In pre-election documents
seen by The Australian Financial Review, the WA racing industry outlined that it wanted
continued financial support, and that
uncertainty over the future of the TAB had caused a 40 per cent decline in confidence and investment in thoroughbred, harness and greyhound ownership.
It remains to be
seen how much Hillary Clinton can benefit from the week here in Philadelphia or if Donald Trump will
continue to use
uncertainty and violence in the world to his advantage.
Uncertainty often leads to a flight to safety, and the U.K. gilt market
continues to be
seen as a safe haven.
We may
see a slight uptick as we near the end of 2017, but other than that,
continuing economic and fiscal policy
uncertainties should keep rates low.
NEW YORK — Despite
continued uncertainty about the economy, many museums
saw improvements in their financial health last year, reaping the benefits of cutbacks and other cautionary fiscal measures taken in the recent past.
I've
seen other comments that point out the variability of the data points, in terms of
uncertainties, and also the recent study about removing temporary negative and positive influences on temperature, showing a definite
continuing warming trend.
Although researchers may still largely be dealing in
uncertainties when it comes to predicting Greenland's exact fate, the data and observations that
continue to trickle in suggest a «greener» (
see: ice - free) future for the island nation.
It will be interesting to
see if this
continues through the bonus season against a backdrop of more
uncertainty regarding Brexit, European elections and maybe a UK general election.
Despite
uncertainty in the financial markets, a report from Robert Half International in Canada indicates in - house departments and law firms will
continue to be hiring in the fourth quarter with corporate law and litigation predicted to
see the most growth in the next three months.
If the downward trend of stocks
continues especially because of the political
uncertainties around the Trump administration, we might
see investors look in the direction of Bitcoin to protect their wealth given that the government does not control it.
Carl Gilleard said: «With the graduate job market inextricably linked to business confidence, it is reassuring to
see that employers are committed to investing in graduate talent despite the backdrop of
continuing global economic
uncertainty.
While we have
seen indications of improving economic activity in recent months — especially the strengthening of private sector employment — consumers» attitudes improved only marginally, and in some areas not at all, from a year ago, reflecting the
continued unevenness and
uncertainty of this recovery.»
While some investors may take a wait - and -
see approach to betting their money on U.S. commercial real estate assets in the short term given the
uncertainty surrounding U.S. economic policy under the new President Elect, «capital formation globally
continues to grow and increase allocations to real estate,» according to Byron Carlock, real estate practice leader with consulting firm PwC, who is currently in London for an investment conference.
Times Square, despite the
uncertainty plaguing office leasing in this market segment,
continued its evolution as the city's most dynamic retail environment, and
saw deals completed by Swatch, Quicksilver, Champs, Foot Locker, Red Lobster and Skechers, among others.
Despite Economic and Regulatory
Uncertainties, Most
See Continued Growth in US Debt and Equity Markets